BlueCrest Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

BlueCrest Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,192	Closed	-$224K	–	358
2023 Q1	$224K	Buy	+9,192	New	+$268K	0.01%	249
2018 Q4	–	Sell	-2,939	Closed	-$289K	–	1501
2018 Q3	$289K	Sell	2,939 -207	-7%	-$22.4K	0.01%	1062
2018 Q2	$364K	Buy	+3,146	New	+$346K	0.01%	1002
2015 Q4	–	Sell	-8,506	Closed	-$1.22M	–	1232
2015 Q3	$1.22M	Buy	+8,506	New	+$1.19M	0.04%	401

Other funds holding TARO

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BlueCrest Capital Management's TARO Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2023, closing a stake of 9,192 shares — an estimated $224K sold.

BlueCrest Capital Management first reported a position in TARO in Q3 2015 and held it in 4 quarters. The position peaked at $1.22M in Q3 2015. 71 funds tracked by Wall St. Rank hold TARO as of Q2 2023.

BlueCrest Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2023 after selling out during the quarter.
BlueCrest Capital Management sold 9,192 Taro Pharmaceutical Industries Ltd. shares in Q2 2023, an estimated $224K.
BlueCrest Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and held it in 4 quarters.
BlueCrest Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $1.22M in Q3 2015.
71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.